ADENOSINE-DEAMINASE AND THYMOCYTE MATURATION

被引:12
|
作者
DOHERTY, PJ
PAN, S
MULLOY, JC
THOMPSON, E
THORNER, P
BARANKIEWIECZ, J
ROIFMAN, CM
COHEN, A
机构
[1] HOSP SICK CHILDREN,DIV IMMUNOL RHEUMATOL,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA
[2] HOSP SICK CHILDREN,DIV PATHOL,TORONTO M5G 1X8,ONTARIO,CANADA
[3] UNIV MED & DENT NEW JERSEY,DEPT PATHOL,PISCATAWAY,NJ 08854
[4] GENESIA,SAN DIEGO,CA
关键词
D O I
10.1111/j.1365-3083.1991.tb01788.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The congenital absence of adenosine deaminase in humans results in severe combined immunodeficiency. To clarify the process whereby thymocytes are destroyed in the absence of adenosine deaminase activity, we induced a parallel condition in mice through the injection of an inhibitor of adenosine deaminase, deoxycoformycin. We have observed that deoxycoformycin, in addition to maintaining high levels of dATP in thymocytes, blocks the progression of thymocyte differentiation at two points. As a result of the first block, the cortex is depleted of immature cortical thymocytes while CD4+CD8+ thymocytes with functionally rearranged T-cell receptors survive. As a result of the second block, the CD4+CD8+ thymocytes are prevented from further differentiation to mature CD4+CD8- or CD4-CD8+ T lymphocytes and accumulate at the corticomedullar junction and in the medulla. These observations suggest that the maintenance of dNTP pools by adenosine deaminase is critical to at least two stages of thymocyte differentiation.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 50 条
  • [1] REGULATION OF THYMOCYTE PROLIFERATION BY ENDOGENOUS ADENOSINE AND ADENOSINE-DEAMINASE
    SANDBERG, G
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1983, 5 (04): : 259 - 265
  • [2] CONSEQUENCES OF ADENOSINE-DEAMINASE DEFICIENCY ON THYMOCYTE METABOLISM
    THUILLIER, L
    GARREAU, F
    CARTIER, PH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (10) : 788 - 794
  • [3] ROLE FOR ADENOSINE-DEAMINASE IN HUMAN MONOCYTE MATURATION
    FISCHER, D
    VANDERWEYDEN, MB
    SNYDERMAN, R
    KELLEY, WN
    JOURNAL OF CLINICAL INVESTIGATION, 1976, 58 (02): : 399 - 407
  • [4] ADENOSINE-DEAMINASE AND HUMAN MONOCYTE-MACROPHAGE MATURATION
    FISHER, D
    VANDERWEYDEN, MB
    SNYDERMAN, R
    KELLEY, WN
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1976, 14 (06): : 286 - 286
  • [5] ADENOSINE-DEAMINASE
    SEDIVA, K
    VOTRUBA, I
    HOLY, A
    CHEMICKE LISTY, 1987, 81 (01): : 46 - 72
  • [6] ADENOSINE-DEAMINASE INHIBITORS - DIFFERENTIAL EFFECTS ON MULTIPLE FORMS OF ADENOSINE-DEAMINASE
    CONSTINE, J
    GLAZER, RI
    JOHNS, DG
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1978, 85 (01) : 198 - 202
  • [7] LOCALIZATION OF ADENOSINE-DEAMINASE AND ADENOSINE-DEAMINASE COMPLEXING PROTEIN IN RABBIT BRAIN
    SCHRADER, WP
    WEST, CA
    STROMINGER, NL
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1987, 35 (04) : 443 - 451
  • [8] ADENOSINE-DEAMINASE DEFICIENCY
    HIRSCHHORN, R
    HOSPITAL PRACTICE, 1987, 22 (06): : 149 - &
  • [9] INHIBITORS OF ADENOSINE-DEAMINASE
    AGARWAL, RP
    PHARMACOLOGY & THERAPEUTICS, 1982, 17 (03) : 399 - 429
  • [10] TREATMENT OF ADENOSINE-DEAMINASE DEFICIENCY WITH POLYETHYLENE GLYCOL-MODIFIED ADENOSINE-DEAMINASE
    GIRAULT, D
    LEDEIST, F
    DEBRE, M
    PERIGNON, JL
    HERBELIN, C
    GRISCELLI, C
    SCIUDERY, D
    HERSHFIELD, M
    FISCHER, A
    ARCHIVES FRANCAISES DE PEDIATRIE, 1992, 49 (04): : 339 - 343